These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 23989197)
1. Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer. Chavarro JE; Kenfield SA; Stampfer MJ; Loda M; Campos H; Sesso HD; Ma J Am J Epidemiol; 2013 Oct; 178(8):1246-55. PubMed ID: 23989197 [TBL] [Abstract][Full Text] [Related]
2. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study. Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385 [TBL] [Abstract][Full Text] [Related]
3. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study. Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Wu JH; Lemaitre RN; Manichaikul A; Guan W; Tanaka T; Foy M; Kabagambe EK; Djousse L; Siscovick D; Fretts AM; Johnson C; King IB; Psaty BM; McKnight B; Rich SS; Chen YD; Nettleton JA; Tang W; Bandinelli S; Jacobs DR; Browning BL; Laurie CC; Gu X; Tsai MY; Steffen LM; Ferrucci L; Fornage M; Mozaffarian D Circ Cardiovasc Genet; 2013 Apr; 6(2):171-83. PubMed ID: 23362303 [TBL] [Abstract][Full Text] [Related]
5. Red blood cell MUFAs and risk of coronary artery disease in the Physicians' Health Study. Matsumoto C; Matthan NR; Lichtenstein AH; Gaziano JM; Djoussé L Am J Clin Nutr; 2013 Sep; 98(3):749-54. PubMed ID: 23824727 [TBL] [Abstract][Full Text] [Related]
6. A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma. Chiu YH; Bertrand KA; Zhang S; Laden F; Epstein MM; Rosner BA; Chiuve S; Campos H; Giovannucci EL; Chavarro JE; Birmann BM Int J Cancer; 2018 Oct; 143(8):1914-1922. PubMed ID: 29756258 [TBL] [Abstract][Full Text] [Related]
7. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study. Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839 [TBL] [Abstract][Full Text] [Related]
8. Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study. Yang M; Ayuningtyas A; Kenfield SA; Sesso HD; Campos H; Ma J; Stampfer MJ; Chavarro JE Cancer Causes Control; 2016 Sep; 27(9):1153-61. PubMed ID: 27488836 [TBL] [Abstract][Full Text] [Related]
9. Plasma fatty acids in de novo lipogenesis pathway are associated with diabetogenic indicators among adults: NHANES 2003-2004. Yu EA; Hu PJ; Mehta S Am J Clin Nutr; 2018 Sep; 108(3):622-632. PubMed ID: 30535092 [TBL] [Abstract][Full Text] [Related]
10. Effect Modification by Time Since Blood Draw on the Association Between Circulating Fatty Acids and Prostate Cancer Risk. Yang M; Sesso HD; Colditz GA; Ma J; Stampfer MJ; Chavarro JE J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27297429 [TBL] [Abstract][Full Text] [Related]
12. A prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Chavarro JE; Stampfer MJ; Campos H; Kurth T; Willett WC; Ma J Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):95-101. PubMed ID: 18199715 [TBL] [Abstract][Full Text] [Related]
13. Association between carbohydrate intake and fatty acids in the de novo lipogenic pathway in serum phospholipids and adipose tissue in a population of Swedish men. Alsharari ZD; Leander K; Sjögren P; Carlsson A; Cederholm T; de Faire U; Hellenius ML; Marklund M; Risérus U Eur J Nutr; 2020 Aug; 59(5):2089-2097. PubMed ID: 31350637 [TBL] [Abstract][Full Text] [Related]
14. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese. Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879 [TBL] [Abstract][Full Text] [Related]
15. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies. Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938 [TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study. Chajès V; Assi N; Biessy C; Ferrari P; Rinaldi S; Slimani N; Lenoir GM; Baglietto L; His M; Boutron-Ruault MC; Trichopoulou A; Lagiou P; Katsoulis M; Kaaks R; Kühn T; Panico S; Pala V; Masala G; Bueno-de-Mesquita HB; Peeters PH; van Gils C; Hjartåker A; Standahl Olsen K; Borgund Barnung R; Barricarte A; Redondo-Sanchez D; Menéndez V; Amiano P; Wennberg M; Key T; Khaw KT; Merritt MA; Riboli E; Gunter MJ; Romieu I Ann Oncol; 2017 Nov; 28(11):2836-2842. PubMed ID: 28950350 [TBL] [Abstract][Full Text] [Related]
17. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study. Jacobs S; Jäger S; Jansen E; Peter A; Stefan N; Boeing H; Schulze MB; Kröger J PLoS One; 2015; 10(5):e0127368. PubMed ID: 25984792 [TBL] [Abstract][Full Text] [Related]
18. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study. Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077 [TBL] [Abstract][Full Text] [Related]
19. Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver. Gnoni A; Giudetti AM J Physiol Biochem; 2016 Sep; 72(3):485-94. PubMed ID: 27312217 [TBL] [Abstract][Full Text] [Related]
20. Prospective study of plasma fatty acids and risk of prostate cancer. Gann PH; Hennekens CH; Sacks FM; Grodstein F; Giovannucci EL; Stampfer MJ J Natl Cancer Inst; 1994 Feb; 86(4):281-6. PubMed ID: 8158682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]